#USA #New York #Halper Sadeh #STAA #YMAB

Halper Sadeh LLC Investigates Potential Violations by STAA, YMAB, and DNOW

Halper Sadeh LLC, a prominent law firm dedicated to safeguarding investor rights, has recently announced an investigation into several companies alleging possible violations of federal securities laws and breaches of fiduciary duties concerning their business transactions. The firm is particularly focusing on STAAR Surgical Company (NASDAQ: STAA), Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB), and DNOW Inc. (NYSE: DNOW). This initiative aims to ensure shareholders are fully informed of their rights and available options.

STAAR Surgical Company (STAA)

The investigation centers around STAAR Surgical, which has recently agreed to sell its operations to Alcon for a cash price of $28.00 per share. The firm is scrutinizing whether shareholders are receiving fair value and any relevant disclosures regarding this sale. Halper Sadeh LLC is prepared to explore options for shareholders to possibly seek increased compensation, while ensuring all necessary information is disclosed. If you're a shareholder of STAAR, you are encouraged to reach out to learn about your rights.

Y-mAbs Therapeutics, Inc. (YMAB)

Simultaneously, Y-mAbs Therapeutics announced a deal to sell to SERB Pharmaceuticals at a cash price of $8.60 per share. The move has raised questions among shareholders regarding the fairness of the offered sale price and whether the company has adequately fulfilled its fiduciary duties. Halper Sadeh LLC is investigating these aspects, with a focus on maximizing shareholder benefits and ensuring full transparency about the transaction. Shareholders of Y-mAbs can also inquire about their legal rights and the potential for further actions.

DNOW Inc. (DNOW)

The case of DNOW is particularly interesting as the company is in the midst of a merger with MRC Global Inc., which would see DNOW shareholders owning approximately 56.5% of the newly formed entity on a fully diluted basis post-merger. Halper Sadeh LLC's investigation will assess whether this merger's terms are equitable for current DNOW shareholders and what additional relief or disclosures may be warranted. Stakeholders are advised to make contact and discuss their legal standing regarding the merger.

How Halper Sadeh LLC Can Assist

Halper Sadeh LLC operates on a contingent fee basis, which means that shareholders won’t incur any out-of-pocket expenses during these investigations unless the firm successfully recovers compensation on behalf of the investors involved. This lowers the barrier to pursuing claims against companies that may have acted improperly or failed to put shareholders' interests first.

To Learn More

Investors focused on these companies have the opportunity to speak with the attorneys at Halper Sadeh LLC on a completely confidential basis. The firm has a history of advocating for investors globally and achieving significant recoveries for those affected by corporate misconduct and securities fraud. Permissions for potential actions, and proactive measures are encouraged to ensure shareholders’ legal rights are protected. Interested individuals can contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or reach out via email at [email protected] or [email protected].

Halper Sadeh LLC is well-known for its investment in corporate reform and for enriching victims of securities fraud. Shareholders with concerns about STAA, YMAB, or DNOW should consult with the legal experts at Halper Sadeh LLC to learn about their options and understand the legal landscape surrounding these cases.

Halper Sadeh LLC emphasizes that prior results in legal matters do not guarantee future outcomes, but the firm’s persistence and commitment to client interests remain steadfast. For investors considering their next steps, reaching out to Halper Sadeh LLC could be a pivotal decision in ensuring accountability and obtaining justice in these ongoing investigations.